ANIX - Anixa Biosciences, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
4.33 0.16 (3.7%) --- --- --- 0.0 (0.0%) 0.16 (3.7%) --- 0.0 (0.0%)

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.07
Diluted EPS:
-0.07
Basic P/E:
-64.1429
Diluted P/E:
-64.1429
RSI(14) 1m:
64.73
VWAP:
4.48
RVol:
0.5852

Events

Period Kind Movement Occurred At
1m Price decrease 1m 4.38 -0.06 (-1.35%) Oct 15 10:04
60m Price increase 60m 4.47 +0.22 (+5.19%) Oct 15 09:46

Related News